Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial
Diabetes and Vascular Disease Research · 2024
DOI: 10.1177/14791641241283939 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes and Vascular Disease Research, 2024. Verfasst von Jens Trøan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Sirolimus, Percutaneous Coronary Intervention, Absorbable Implants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Biotronik, Terumo.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes mellitus is associated with higher risk of target lesion failure (TLF) after percutaneous coronary intervention. We studied the 5-year outcome in patients with diabetes mellitus treated with biodegradable polymer stents.
Methods
The SORT OUT VII was a randomised trial comparing the ultrathin sirolimus-eluting Orsiro stent (O-SES) and the biolimus-eluting Nobori stent (N-BES) in an all-comer setting. Patients ( n = 2525) were randomised to receive O-SES ( n = 1261, diabetes: n = 236) or N-BES ( n = 1264, diabetes: n = 235). Endpoints were TLF (a composite of cardiac death, target-lesion myocardial infarction (MI), target lesion revascularization (TLR)), definite stent thrombosis and a patient related outcome (all-cause mortality, MI and revascularization) within 5 years.
Results
Patients with diabetes mellitus had higher TLF (20.6% vs 11.0%, (Rate ratio (RR) 1.85 95% confidence interval (CI): (1.42-2.40) and patient related outcome (42.0% vs 31.0%, RR 1.43 95% CI: (1.19-1.71)) compared to patients without diabetes. Among patients with diabetes mellitus, TLF after 5 years did not differ between O-SES and N-BES (21.2% vs 20.0%), RR 1.05 95% CI: (0.70-1.58), p = 0.81). Cardiac death, MI, TLR, and definite stent thrombosis did not differ between the groups.
Conclusion
In patients with diabetes mellitus, 5-year outcomes were similar among patients treated with biodegradable polymer O-SES or N-BES. Clinical trial registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT01879358.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Odense University Hospital, Odense, Denmark.
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Jens Trøan
Förderung
- Biotronik
- Terumo
Zitieren
APA
Trøan, J., Christiansen, E. H., Hansen, K. N., Eftekhari, A., Jakobsen, L., Mæng, M., Freeman, P., Jensen, R. V., Christensen, M. K., Noori, M., Ellert-Gregersen, J., Støttrup, N. B., Kahlert, J., Veien, K. T., & Jensen, L. O. (2024). Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial. Diabetes and Vascular Disease Research. https://doi.org/10.1177/14791641241283939
Vancouver
Trøan J, Christiansen EH, Hansen KN, Eftekhari A, Jakobsen L, Mæng M, et al. Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial. Diabetes and Vascular Disease Research. 2024. doi:10.1177/14791641241283939
BibTeX
@article{Tran2024,
author = {Trøan, Jens and Christiansen, Evald Høj and Hansen, Kirstine Nørregaard and Eftekhari, Ashkan and Jakobsen, Lars and Mæng, Michael and Freeman, Phillip and Jensen, Rebekka Vibjerg and Christensen, Martin Kirk and Noori, Manijeh and Ellert-Gregersen, Julia and Støttrup, Nicolaj Brejnholt and Kahlert, Johnny and Veien, Karsten Tange and Jensen, Lisette Okkels},
title = {Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial},
journal = {Diabetes and Vascular Disease Research},
year = {2024},
doi = {10.1177/14791641241283939}
}
EUVIMED